IDH1 and glioblastoma: The results showed that the five-mRNA signature was substantially linked with survival when adjusted for IDH1 mutation and MGMT promoter methylation status, indicating that the five-mRNA signature’s predictive potential for GBM survival is also independent of these two molecular features (Figure 9B).